Full Text View
Tabular View
No Study Results Posted
Related Studies
Longitudinal Antimalarial Combinations in Uganda
This study has been completed.
Study NCT00123552   Information provided by University of California, San Francisco

First Received on July 22, 2005.   Last Updated on November 28, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
Amodiaquine+Artesunate
Artemether+Lumefantrine
Additional drug interventions recognized in this trial
Amodiaquine
Antimalarials
Artemether
Artemether-lumefantrine combination
Artemisinins
Artesunate
Lumefantrine
Pyrimethamine
Sulfadoxine
More general drug interventions related to this trial
Amebicides
Anthelmintics
Anti-Infective Agents
Anti-Infective Agents, Urinary
Antifungal Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Coccidiostats
Enzyme Inhibitors
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Renal Agents
Schistosomicides
Therapeutic Uses
Sponsors listed in this trial
University of California, San Francisco
National Institute of Allergy and Infectious Diseases (NIAID)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services